Efficacy Endpoints of RTOG 0247: A Randomized Phase II Study of Neoadjuvant Radiation Therapy Plus Concurrent Capecitabine and Irinotecan or Capecitabine and Oxaliplatin for Patients with Locally Advanced Rectal Cancer

PURPOSE/OBJECTIVES: Primary endpoint analysis of RTOG 0247 demonstrated preoperative RT with capecitabine plus oxaliplatin achieved a pCR pre-specified threshold (21%) to merit further study, whereas the RT with capecitabine plus irinotecan arm did not (10%). Secondary efficacy endpoints are reporte...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Radiat Oncol Biol Phys
Main Authors: Wong, Stuart J., Moughan, J., Meropol, Neal J., Anne, Pramila Rani, Kachnic, Lisa A., Rashid, Asif, Watson, James C., Mitchell, Edith P., Pollock, Jondavid, Lee, R. Jeffrey, Haddock, Michael, Erickson, Beth A., Willett, Christopher G.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4385459/
https://ncbi.nlm.nih.gov/pubmed/25446610
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2014.09.031
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados